Suchergebnisse
SanDisk Slumps on Soft Guidance: Should You Buy the Dip With ETFs?
SanDisk SNDK shares fell as much as 8% in after-hours trading on Aug. 5, 2026, after the flash memory and storage maker issued fiscal first-quarter revenue guidance that missed Wall Street
Is VLTO Worth Buying as Growth Improves but Valuation Stays Rich?
Veralto Corporation VLTO is showing better earnings momentum, resilient recurring revenues and ample liquidity. Those qualities strengthen the investment case as management expects growth to
Charles River Associates Q2 Earnings Call Highlights
Key Points
- Interested in Charles River Associates? Here are five stocks we like better.
- Record Q2 performance: Revenue rose 12.8% year over year to $210.8 million, while non-GAAP EPS increased
Should You Buy, Sell or Hold Eaton Stock Post Q2 Earnings?
Eaton Corporation ETN posted solid second-quarter 2026 results, with both the top and bottom lines improving year over year as well as beating the Zacks Consensus Estimate. The quarter benefited
Should Investors Hold on to Astera Labs Stock Post Q2 Earnings?
Astera Labs ALAB shares have lost 12% since it reported second-quarter 2026 results on Aug. 4, 2026. The company’s second-quarter earnings suffered from higher operating expenses due to continued
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
AngioDynamics, Inc. ANGO offers investors a clear trade-off. Its Med Tech platforms are expanding quickly, but near-term earnings conversion remains weak as tariffs and operating costs absorb part
Avino Silver (ASM) Suffers a Larger Drop Than the General Market: Key Insights
Avino Silver (ASM) ended the recent trading session at $6.38, demonstrating a -1.54% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily loss of
Astrana Health Q2 Earnings Call Highlights
Key Points
- Interested in Astrana Health, Inc.? Here are five stocks we like better.
- Strong second-quarter results: Revenue rose 49% year over year to $973 million, adjusted EBITDA increased
Assured Guaranty (AGO) Q2 Earnings Lag Estimates
Assured Guaranty (AGO) came out with quarterly earnings of $1.23 per share, missing the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.01 per share a year ago. These
Trading Klaveness Com. Carriers As
Trading Klaveness Com. Carriers As
Klaveness Com. Carriers As diskutieren
Klaveness Com. Carriers As diskutieren
EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: Asklepios Kliniken GmbH & Co. KGaA übermittelt Verlangen zur Durchführung eines Squeeze-out der Minderheitsaktionäre der RHÖN-Klinikum Aktiengesellschaft
EQS-Adhoc: Asklepios Kliniken GmbH & Co. KGaA submits request for the implementation of a squeeze-out of the minority shareholders of RHÖN-Klinikum Aktiengesellschaft
Genel Energy PLC: Response to announcement made by DNO ASA
4 Healthcare Stocks to Watch as Defensive Demand Strengthens
The healthcare sector has quietly regained momentum in 2026, with the benchmark State Street Health Care Select Sector SPDR ETF (XLV) advancing 7.1% year to date as of Aug. 6. Investors have
Net Asset Value(s)
Manhattan Associates (MANH) Now Trades Above Golden Cross: Time to Buy?
Manhattan Associates, Inc. (MANH) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, MANH's 50-day simple moving average broke out
Is AGC Inc. - Unsponsored ADR (ASGLY) Stock Outpacing Its Conglomerates Peers This Year?
Investors interested in Conglomerates stocks should always be looking to find the best-performing companies in the group. Has AGC Inc. - Unsponsored ADR (ASGLY) been one of those stocks this year
Down 10.2% in 4 Weeks, Here's Why You Should You Buy the Dip in American Assets Trust (AAT)
A downtrend has been apparent in American Assets Trust (AAT) lately with too much selling pressure. The stock has declined 10.2% over the past four weeks. However, given the fact that it is now in
ATI Q2 Earnings Call Highlights AA&S Margin Growth and '26 Outlook
ATI Inc. ATI used its second-quarter call to frame Advanced Alloys & Solutions as a stronger earnings contributor, while reaffirming High Performance Materials & Components as its main long-term





